PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Mutations in the PTEN induced putative kinase 1 (PINK1) gene cause an autosomal recessive form of Parkinson disease (PD). So far, no substrates of PINK1 have been reported, and the mechanism by which PINK1 mutations lead to neurodegeneration is unknown. Here we report the identification of TNF receptor-associated protein 1 (TRAP1), a mitochondrial molecular chaperone also known as heat shock protein 75 (Hsp75), as a cellular substrate for PINK1 kinase. PINK1 binds and colocalizes with TRAP1 in the mitochondria and phosphorylates TRAP1 both in vitro and in vivo. We show that PINK1 protects against oxidative-stress-induced cell death by suppressing cytochrome c release from mitochondria, and this protective action of PINK1 depends on its kinase activity to phosphorylate TRAP1. Moreover, we find that the ability of PINK1 to promote TRAP1 phosphorylation and cell survival is impaired by PD-linked PINK1 G309D, L347P, and W437X mutations. Our findings suggest a novel pathway by which PINK1 phosphorylates downstream effector TRAP1 to prevent oxidative-stress-induced apoptosis and implicate the dysregulation of this mitochondrial pathway in PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Phosphorylation of TRAP1 by Wild-Type and Mutant PINK1 (A) In vitro kinase assays were performed by incubation of purified TRAP1 with [γ32-P] ATP in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Phosphorylated TRAP1 was visualized by autoradiography (top panel). PINK1 and TRAP1 proteins used in the kinase assays were shown by immunoblotting with anti-TRAP1 (middle panel) and anti-FLAG antibodies (bottom panel). (B) Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. *Significantly different from the wild-type PINK1 (p < 0.01). (C) PC12 cells expressing wild-type or mutant PINK1 or vector-transfected controls were treated with 400 μM H2O2 as indicated. In vivo phosphorylation of endogenous TRAP1 was determined by immunoprecipitation with anti-TRAP1 antibody followed by immunoblotting using anti-phosphoserine (upper panel) and anti-TRAP1 (lower panel) antibodies. (D) Normalized levels of in vivo TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± SEM from three independent experiments. aSignificantly different from the corresponding H2O2-treated vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01). AU, arbitrary units.](https://figures.cochat.ai/paper-figures/17d4ebdc4d0a46a99e4bb1385a64faa3/pink1-protects-against-oxidative-stress-by-phosphorylating-mitochondrial-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Normally, PINK1 serves a protective role by helping to produce the PTEN-induced kinase protein, which shields mitochondria from damage caused by the reactive oxygen species (ROS) [140].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [140]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911 · cited 1×
“Biochemical assays of cytochrome c release were performed as described [40].”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 2×
“served serine/threonine kinase domain [5].”
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · cited 1×
“Postmortem analyses reveal a deficiency in the mitochondrial complex I function in patients with sporadic PD [3].”
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 1×
“loss of PINK1 leads to mitochondrial defects and degeneration of muscle and dopaminergic neurons [”
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“dopaminergic neurons [17–20].”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“In vitro kinase assays were performed as described [33] by incubation of affinity-purified FLAG-tagged wild-type or mutant PINK1 with TRAP1 for 20 min at 30 8C in 100 ll of reaction buffer containing 50 mM Tris-HCl (pH 7.”
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116 · cited 1×
“PC12 cells were treated with H2O2 as indicated, and cell viability was assessed using the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described [38].”
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024 · cited 1×
“of cellular processes, including cell survival and apoptosis [24, 25 ].”
Research works printed but not linked: 41
- Lang, 1998, N Engl J Med, 339, 1044
- Farrer, 2006, Nat Rev Genet, 7, 306
- Schapira, 1989, Lancet, 1, 1269
- Betarbet, 2002, Bioessays, 24, 308
- Valente, 2004, Science, 304, 1158
- Hatano, 2004, Ann Neurol, 56, 424
- Bonifati, 2005, Neurology, 65, 87
- Zadikoff, 2006, Mov Disord, 21, 875
- Hedrich, 2006, Arch Neurol, 63, 833
- Criscuolo, 2006, Mov Disord, 21, 1265
- Beilina, 2005, Proc Natl Acad Sci U S A, 102, 5703
- Silvestri, 2005, Hum Mol Genet, 14, 3477
- Gandhi, 2006, Brain, 129, 1720
- Nakajima, 2003, Cancer Lett, 201, 195
- Petit, 2005, J Biol Chem, 280, 34025
- Deng, 2005, Biochem Biophys Res Commun, 337, 1133
- Clark, 2006, Nature, 441, 1162
- Park, 2006, Nature, 441, 1157
- Wang, 2006, Proc Natl Acad Sci U S A, 103, 13520
- Yang, 2006, Proc Natl Acad Sci U S A, 103, 10793
- Song, 1995, J Biol Chem, 270, 3574
- Chen, 1996, Mol Cell Biol, 16, 4691
- Felts, 2000, J Biol Chem, 275, 3305
- Beere, 2005, J Clin Invest, 115, 2633
- Muchowski, 2005, Nat Rev Neurosci, 6, 11
- Masuda, 2004, J Biol Chem, 279, 42503
- Sim, 2006, Hum Mol Genet, 15, 3251
- Olzmann, 2004, J Biol Chem, 279, 8506
- Chin, 2000, J Biol Chem, 275, 1191
- Choi, 2004, J Biol Chem, 279, 13256
- Choi, 2006, J Biol Chem, 281, 10816
- Chin, 2001, J Biol Chem, 276, 7069
- Ninomiya-Tsuji, 1999, Nature, 398, 252
- Lewis Carl, 1993, J Histochem Cytochem, 41, 1273
- Li, 2002, J Biol Chem, 277, 28212
- Hovius, 1990, Biochim Biophys Acta, 1021, 217
- Kirk, 2006, J Cell Sci, 119, 4689
- Canet-Aviles, 2004, Proc Natl Acad Sci U S A, 101, 9103
- Chen, 2001, Proc Natl Acad Sci U S A, 98, 7783
- Yang, 1997, Science, 275, 1129
- Sherer, 2002, J Neurosci, 22, 7006
Cited by
Items 401–500 of 596
Kaur, I., Behl, T., Sehgal, A., Singh, S., Sharma, N., Aleya, L., & BUNGAU, S. G. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14619-6 · Cited by 20
“Furthermore, the mitochondrial molecular chaperone hsp (heat shock protein) 75 kDa is known to be phosphorylated by PINK1 (Pridgeon et al. 2007).”
BackgroundTargeting Mitochondria as a Therapeutic Approach for Parkinson’s Disease
Abrishamdar, M., Jalali, M. S., & Farbood, Y. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01265-w · Cited by 25
Potential therapeutic targets for Parkinson's disease
Stoessl, A. J. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.4.425 · Cited by 26
“Although its precise function is unknown, PINK1 resides in the mitochondrial inter-membrane space and recent evidence suggests that it too may protect against oxidative stress by phosphorylation of the mitochondrial chaperone TNF receptor-associate protein 1 (TRAP1) [85] .”
C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets
Vistbakka, J., VanDuyn, N., Wong, G., & Nass, R. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311211080004 · Cited by 24
“PINK1 also functions to reduce oxidative stress and prevent the release of cytochrome c via phosphorylation of one of its endogenous substrates [82].”
BackgroundPapa, S., Sardanelli, A. M., Capitanio, N., & Piccoli, C. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9252-4 · Cited by 22
Keyser, R. J., Lesage, S., Brice, A., Carr, J. A., & Bardien, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.049 · Cited by 22
Zafar, A., Jabbar, M., Manzoor, Y., Gulzar, H., Hassan, S. G., Nazir, M. A., Ain-ul-Haq, Mustafa, G., Sahar, R., Masood, A., et al. (2020) · Protein and Peptide Letters · doi:10.2174/0929866527666200110155609 · Cited by 21
PINK1 and Parkin: The odd couple
Yoboue, E. D., & Valente, E. M. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.04.007 · Cited by 23
Fu, X., Liu, H., Liu, J., DiSanto, M. E., & Zhang, X. (2022) · Cells · doi:10.3390/cells11132052 · Cited by 20
“Mortalin has been reported to prevent the release of oxidant-induced cytochrome c from mitochondria [109].”
BackgroundParkinson’s disease: what the model systems have taught us so far
Ghatak, S., Trudler, D., Dolatabadi, N., & Ambasudhan, R. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0960-6 · Cited by 23
The PTEN and Myotubularin Phosphoinositide 3-Phosphatases: Linking Lipid Signalling to Human Disease
Davies, E. M., Sheffield, D. A., Tibarewal, P., Fedele, C. G., Mitchell, C. A., & Leslie, N. R. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-3012-0_8 · Cited by 19
Büchel, F., Saliger, S., Dräger, A., Hoffmann, S., Wrzodek, C., Zell, A., & Kahle, P. J. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-136 · Cited by 21
“Parkin inhibits, similar to phosphorylated TRAP1, the release of cytochrome C and consequently, Parkin and TRAP prevent apoptosis [35-37].”
BackgroundProfibrotic IHG-1 complexes with renal disease associated HSPA5 and TRAP1 in mitochondria
Bhreathnach, Ú., Griffin, B., Brennan, E. P., Ewart, L. M., Higgins, D. F., & Murphy, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.01.015 · Cited by 20
Tsai, H.-Y., Bronner, M. P., March, J. K., Valentine, J. F., Shroyer, N. F., Lai, L. A., Brentnall, T. A., Pan, S., & Chen, R. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215915 · Cited by 21
PINK1 activation–turning on a promiscuous kinase
Aerts, L., Strooper, B. D., & Morais, V. A. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150002 · Cited by 22
Xu, Y., Zhi, F., Peng, Y., Shao, N., Khiati, D., Balboni, G., Yang, Y., & Xia, Y. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1043-7 · Cited by 19
Mitochondrial disfunction in Parkinson's disease
Бунеева, О. А., & Medvedev, A. E. (2011) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20115703246 · Cited by 18
Stankiewicz, M., & Mayer, M. P. (2011) · BioMolecular Concepts · doi:10.1515/bmc.2011.054 · Cited by 22
Beinlich, F. R. M., Drees, C., Piehler, J., & Busch, K. B. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00295 · Cited by 19
Guardian of the Furnace: Mitochondria, TRAP1, ROS and stem cell maintenance
Kadye, R., Kramer, A. H., Joos-Vandewalle, J., Parsons, M., Njengele‐Tetyana, Z., Hoppe, H. C., & Prinsloo, E. (2013) · IUBMB Life · doi:10.1002/iub.1234 · Cited by 19
Berthier, A., Jiménez-Sáinz, J., & Pulido, R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216844110 · Cited by 16
“Pridgeon JW, Olzmann JA, Chin LS, Li L (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.”
BackgroundRetractedPINK1 phosphorylates transglutaminase 2 and blocks its proteasomal degradation
Min, B., Kwon, Y.-C., Choe, K., & Chung, K. C. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23535 · Cited by 17
“For example, PINK1-mediated TRAP1 phosphorylation prevents oxidative stressinduced apoptosis and promotes cell survival (Pridgeon et al., 2007).”
BackgroundPINK1 in mitochondrial function
Plun‐Favreau, H., & Hardy, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805908105 · Cited by 17
“PINK1 has been shown to phosphorylate the mitochondrial chaperone TRAP1, protecting against oxidative stress-induced apoptosis (20) and to be important for the phosphorylation of HtrA2 upon activation of the p38 pathway, preventing mitochondrial stress (21).”
BackgroundMitochondrial Chaperone Code: Just warming up
Perez, R. F., Mochi, G., Khan, A., & Woodford, M. R. (2024) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2024.05.002 · Cited by 17
“23 This study found that PINK1 phosphorylated TRAP1, inhibited the release of cytochrome c , and in turn decreased oxidative stress allowing the evasion of oxidative stress-induced apoptosis.”
BackgroundMitochondria in neurodegeneration
Chu, C. T. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100532 · Cited by 18
Function of α-synuclein and PINK1 in Lewy body dementia (Review)
Minami, A., NAKANISHI, A., Matsuda, S., Kitagishi, Y., & Ogura, Y. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1980 · Cited by 18
“It has been shown to phosphorylate the mitochondrial heat shock protein 75 kDa [tumor necrosis factor receptor-associated protein-1 (TRAP1)], increasing neuronal survival against heat shock or oxidative stress by preventing the release of cytochrome c (47).”
Altered transcription factor trafficking in oxidatively-stressed neuronal cells
Patel, V. P., DeFranco, D. B., & Chu, C. T. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.08.002 · Cited by 16
The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease
Huang, C., Bian, J., Cao, Q., Chen, X., & Pollock, C. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041525 · Cited by 20
“N-terminally truncated, cytosolic PINK1 protects against oxidative stress-induced apoptosis by phosphorylating the tumour necrosis factor receptorassociated protein 1 (TRAP1)/heat shock protein 75 (Hsp75), a member of the HSP90 family of the mitochondrial chaperone [23] and serine protease high-temperature-requirement…”
BackgroundPetruzzella, V., Sardanelli, A. M., Scacco, S., Panelli, D., Papa, F., Trentadue, R., & Papa, S. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_17 · Cited by 17
Bottoni, P., Giardina, B., & Scatena, R. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800195 · Cited by 20
Rasola, A., & Bernardi, P. (2015) · Cell Calcium · doi:10.1016/j.ceca.2015.03.004 · Cited by 19
TRAP1: A Metabolic Hub Linking Aging Pathophysiology to Mitochondrial S-Nitrosylation
Faienza, F., Rizza, S., Giglio, P., & Filomeni, G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00340 · Cited by 17
Oxidative Stress in Parkinson's Disease
Vaya, J., Aluf, Y., & Finberg, J. P. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9_12 · Cited by 16
Wood‐Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A. Y., Miljan, E., Keen, G., Stanyer, L., Hargreaves, I. P., Klupsch, K., Deas, E., et al. (2008) · PLoS ONE · doi:10.1371/annotation/17d5aaa1-c6d8-4aad-a9a4-56b2c1220c83 · Cited by 17
PINK1 signalling in neurodegenerative disease
Whiten, D. R., Cox, D., & Sue, C. M. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210036 · Cited by 15
Kim, J. J., Daadi, E. W., Oh, T. T., Daadi, E. S., & Daadi, M. M. (2022) · Genes · doi:10.3390/genes13111937 · Cited by 14
Vandhana, S., Lakshmi, T. S. R., Indra, D., Deepa, P. R., & Krishnakumar, S. (2012) · Current Eye Research · doi:10.3109/02713683.2012.678544 · Cited by 17
In a flurry of PINK, mitochondrial bioenergetics takes a leading role in Parkinson's disease
Murphy, A. N. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900020 · Cited by 17
Chemical Strategies for Activating PINK1, a Protein Kinase Mutated in Parkinson's Disease
Lambourne, O. A., & Mehellou, Y. (2018) · ChemBioChem · doi:10.1002/cbic.201800497 · Cited by 18
Genetic Mutations and Mitochondrial Toxins Shed New Light on the Pathogenesis of Parkinson's Disease
Sato, S., & Hattori, N. (2011) · Parkinson s Disease · doi:10.4061/2011/979231 · Cited by 14
“The activity of PINK1 kinase is crucial for mitochondrial maintenance via TRAP phosphorylation [45].”
BackgroundLizama, B. N., Palubinsky, A. M., & McLaughlin, B. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.013 · Cited by 14
“TRAP1 was the first identified in vivo target of PINK1 phosphorylation and is involved in maintaining mitochondrial polarization, ETC complex stabilization, and in controlling the gating of the mitochondrial permeability transition pore (Costa et al., 2013; Pridgeon et al., 2007; Zhang et al., 2013).”
Torii, S., Kasai, S., Yoshida, T., Yasumoto, K., & Shimizu, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041202 · Cited by 16
“Although tumor necrosis factor type 1 receptor–associated protein (TRAP1) and the serine protease HtrA2/Omi have been identified as putative PINK1 targets [30,31], TRAP1 and HtrA2/Omi are localized primarily in the mitochondrial matrix and mitochondrial intermembrane space, respectively.”
BackgroundThe role of heat stress on the age related protein carbonylation
Bozaykut, P., Sözen, E., Kağa, E., Ece, A., Ozaltin, E., Ek, B., Özer, N. K., Grune, T., Bergquist, J., & Karademir-Yilmaz, B. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.06.025 · Cited by 15
Insights into mitochondrial quality control pathways and Parkinson’s disease
Lehmann, S., & Martins, L. M. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1044-y · Cited by 14
“Additionally, PINK1-dependent phosphorylation of the mitochondrial chaperone TRAP1 has been shown to protect mitochondria from stress-inducing agents [18].”
Franks, P. W., Schéele, C., Loos, R. J. F., Nielsen, A. R., Finucane, F. M., Wahlestedt, C., Pedersen, B. K., Wareham, N. J., & Timmons, J. A. (2008) · The FASEB Journal · doi:10.1096/fj.08-107086 · Cited by 14
“The exact role for PINK1 in the cell is unclear, although it has recently been demonstrated to protect against oxidative stress-related damage (13–15) and apoptosis (14, 16).”
BackgroundExpression of TRAP1 Predicts Poor Survival of Malignant Glioma Patients
Li, S., Lv, Q., Sun, H., Xue, Y., Wang, P., Liu, L., Li, Z., Li, Z., Tian, X., & Liu, Y. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0413-5 · Cited by 15
“TRAP1 was also proved to be an independent prognostic factor for overall survival of patients with glioma, which supported the notion that it may be a molecule involved in tumor invasion and metastasis (Pridgeon et al. 2007; Felts et al. 2000; Zuehlke and Johnson 2010).”
BackgroundFrom Genes to Proteins in Mendelian Parkinson's Disease: An Overview
Cetinkaya, C. P., Lesage, S., Brice, A., & Başak, A. N. (2009) · The Anatomical Record · doi:10.1002/ar.20968 · Cited by 15
“TRAP1 is therefore proposed as being a downstream effector of PINK1: when phosphorylated by PINK1, TRAP1 may indirectly suppress cytochrome c release from mitochondria, protecting against oxidative stress-induced cell death (Pridgeon et al., 2007).”
BackgroundExpression of PINK1 in the brain, eye and ear of mouse during embryonic development
d’Amora, M., Angelini, C., Marcoli, M., Cervetto, C., Kitada, T., & Vallarino, M. (2010) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2010.11.004 · Cited by 14
Qin, X., Zheng, C., Yates, J. R., & Liao, L. (2014) · Molecular BioSystems · doi:10.1039/c3mb70565j · Cited by 13
“5 Activated PINK1 kinase phosphorylates Parkin and promotes Parkin-mediated ubiquitination of mitochondrial outer membrane proteins including TRAP1, Mitofusin, Miro and VDAC.(6) 7 8 9 These processes lead to the degradation of ubiquitinated proteins and mitophagy, preventing further damage to cells.”
BackgroundClinically reported heterozygous mutations in the PINK1 kinase domain exert a gene dosage effect
Tan, E., Refai, F. S., Siddique, M. M., Yap, K., Ho, P., Fook-Chong, S. M. C., & Zhao, Y. (2009) · Human Mutation · doi:10.1002/humu.21108 · Cited by 14
“While there has been extensive in vitro and in vivo evidence supporting the proapoptotic activity of PINK1 mutations [AbouSleiman et al., 2006; Clark et al., 2006; Gegg et al., 2009; Mills et al., 2008; Plun-Favreau et al., 2007; Pridgeon et al., 2007; Schapira, 2008; Sim et al., 2006; Yang et al., 2006], unraveling t…”
InfluentialFei, X., Ma, S., Zhang, D., Zhang, Q., & Huang, Y. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.08.041 · Cited by 13
Molecular Perspectives of Mitochondrial Adaptations and Their Role in Cardiac Proteostasis
Alam, S., Abdullah, C. S., Aishwarya, R., Morshed, M., & Bhuiyan, M. S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01054 · Cited by 12
Mani, S., Ralph, S. J., Swargiary, G., Rani, M., Wasnik, S., Singh, M., & Devi, A. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0379 · Cited by 13
“Also, PINK1 mediated TRAP1 phosphorylation was shown to be highly protective against oxidative stress–induced mitochondrial cytochrome c release and apoptotic cell death (Pridgeon et al., 2007).”
Contreras-Zarate, M. J., Niño, A., Rojas, L., Arboleda, H., & Arboleda, G. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0479-0 · Cited by 12
Ganesan, S., & Parvathi, V. D. (2021) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-021-00208-2 · Cited by 12
Mitochondrial PINK1—A Novel Cardioprotective Kinase?
Siddall, H. K., Warrell, C. E., Davidson, S. M., Mocanu, M. M., & Yellon, D. M. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6136-5 · Cited by 12
“Previous studies have shown that, in neuronal tissue, PINK1 protects against oxidative damage by phosphorylating mitochondrial TRAP1 [ 9 ].”
BackgroundLi, Y., Zhang, Y., Wang, T., Podok, P., Xu, D., & Lu, L. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.01.031 · Cited by 12
“PINK1 can interact with Trap1 and the protection of cells from oxidative stress-induced apoptosis by PINK1 could be conducted by phosphorylating Trap1 [22].”
BackgroundTRAP1 and its therapeutic potential
Gutierrez, A. T., Archdeacon, J., & Blagg, B. S. J. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130395 · Cited by 12
Characterizing the role of the dark kinome in neurodegenerative disease – A mini review
Axtman, A. D. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.130014 · Cited by 13
Looyenga, B. D., DeHaan, A. M., & MacKeigan, J. P. (2008) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a003826.01 · Cited by 11
Post-translational modification and mitochondrial function in Parkinson’s disease
Luo, S., Wang, D., & Zhang, Z. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1329554 · Cited by 17
“PD-associated PINK1 mutants G309D and L347P, both with reduced kinase activity, diminish the TRAP1 phosphorylation and result in increased apoptosis upon mitochondrial oxidative stress (Pridgeon et al., 2007).”
BackgroundConstruct, Face, and Predictive Validity of Parkinson’s Disease Rodent Models
Guimarães, R. P., de Resende, M. C. S., Tavares, M. M., de Azevedo, C. V. I. B., Ruiz, M. C. M., & Mortari, M. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168971 · Cited by 19
“The PINK1 protein is also capable of phosphorylating the mitochondrial chaperone TRAP1, protecting it against oxidative stress [108], where the dysregulation of the gene leads to organelle dysfunction.”
BackgroundThe role of mitochondrial remodeling in neurodegenerative diseases
Guan, D., Liang, C., Zheng, D., Liu, S., Luo, J., Cai, Z., Zhang, H., & Chen, J. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2024.105927 · Cited by 11
Deciphering the dual role and prognostic potential of PINK1 across cancer types
Radin, D., Dai, K., & Leonardi, D. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295314 · Cited by 13
“Yet studies have suggested that the kinase activity of PINK1 spans to other substrates, including TRAP1 (Pridgeon et al., 2007), Mfn2 (Chen and Dorn, 2013), Miro (Wang et al.”
BackgroundThe PINK1-Mediated Crosstalk between Neural Cells and the Underlying Link to Parkinson’s Disease
Leites, E. P., & Morais, V. A. (2021) · Cells · doi:10.3390/cells10061395 · Cited by 14
“On the other hand, phosphorylation of mitochondrial chaperone TRAP1 and HtrA2 protects cells from mitochondrial-induced apoptosis [35,36].”
BackgroundClarke, B. E., Kalmár, B., & Greensmith, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031789 · Cited by 11
“Although the role of TRAP1 in the context of neurodegenerative diseases remains relatively unexplored, TRAP1 has been associated with Parkinson’s disease (PD) as an effector for PDassociated protein, PINK1 [5,12].”
BackgroundInfluentialThe development of cancers research based on mitochondrial heat shock protein 90
Xiang, Y., Liu, X., Sun, Q., Liao, K., Liu, X., Zhao, Z., Feng, L., Liu, Y., & Wang, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1296456 · Cited by 10
Richardson, T. E., Orr, M. E., Orr, T. C., Rohde, S. K., Ehrenberg, A. J., Thorn, E. L., Christie, T. D., Almazan, V. F., Afzal, R., Sanctis, C. D., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14487 · Cited by 14
“Proteins involved with response to oxidative stress were more variable; Park7 54,55 was lower in subjects with A β , while PINK1 56 was elevated in subjects with ADNC and definite PART but not possible PART or CTE (and this difference was particularly pronounced in the entorhinal cortex and CA4 subregion [Figure 3A, 5…”
InfluentialBaroli, B. M., Loi, E., Solari, P., Kasture, A. S., Moi, L., Muroni, P., Kasture, S. B., Setzu, M. D., Liscia, A. M., & Zavattari, P. (2019) · The FASEB Journal · doi:10.1096/fj.201901010 · Cited by 11
“Because mitochondria are a primary source of reactive oxygen species, PINK1 deficiency results in increased oxidative stress (33, 34).”
BackgroundSun, Y., Zou, H., Yang, L., Zhou, M., Shi, X., Yang, Y., Chen, W., Zhao, Y., Mo, J., & Lu, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.8774 · Cited by 10
“Although TRAP1 can maintain the mitochondrial integrity and function by inhibiting the fold of damaged proteins and promoting the refold process of denatured proteins, TRAP1 has dual effects on the regulation of mitochondrial apoptosis (36).”
BackgroundChen, F. W., Davies, J. P., Calvo, R., Chaudhari, J., Dolios, G., Taylor, M. K., Patnaik, S., Dehdashti, J., Mull, R., Dranchack, P., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104941 · Cited by 12
“Taken together, the effects of the compounds on mitochondria are consistent with the well-documented protective role of TRAP1 against oxidative stress (Costa et al., 2013; Pridgeon et al., 2007; Yoshida et al., 2013).”
Biochemical properties of the kinase PINK1 as sensor protein for mitochondrial damage signalling
Rüb, C., Schröder, N., & Voos, W. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150005 · Cited by 9
Shin, D.-I., & Oh, Y. J. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.1.65 · Cited by 9
“In these conditions, TRAP1 acts as a mitochondrial chaperone and plays an essential role for maintaining mitochondrial function and regulating cellular apoptosis [43, 46, 52, 53].”
BackgroundInfluentialLee, C.-M., Chien, T.-C. R., Wang, J.-S., Chen, Y.-W., Chen, C., Kuo, C.-C., Chiang, L.-T., Wu, K. K., & Hsu, W.-T. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.010 · Cited by 10
Mitochondria and Parkinson's Disease
Simon, D. K., Chu, C. T., & Swerdlow, R. H. (2011) · Parkinson s Disease · doi:10.4061/2011/261791 · Cited by 9
Mitochondria are devoid of poly(ADP‐ribose)polymerase‐1, but harbor its product oligo(ADP‐ribose)
Köritzer, J., Blenn, C., Bürkle, A., & Beneke, S. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29887 · Cited by 8
“Blocking TRAP1 function has been reported to accelerate mitochondrial loss, especially in cases of oxidative stress.(76) Mortalin is the major chaperone interacting with the transport machinery facilitating protein import into the mitochondrial matrix,(78) and is itself mutated in a familiar form of Parkinson's diseas…”
BackgroundAerts, L., Craessaerts, K., Strooper, B. D., & Morais, V. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146083 · Cited by 8
“HtrA2 [17], TRAP1 [16], Mitofusin 2 [19], Miro [18], NDUFA10 [15], and Bcl-xL [20], is required to unravel the relevance and impact of these differences in activity and of the respective candidate substrates.”
BackgroundInfluentialAlpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
Долгачева, Л. П., Fedotova, E. I., Abramov, A. Y., & Berezhnov, A. V. (2018) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747818010038 · Cited by 9
“Substrates of PINK1 in mitochondria include: (1) Hsp90-like chaperone of the matrix TRAP1 [64]; (2) the intermembrane protease HtrA2/Omi (PARK13) [65]; (3) Miro, Ca2+-binding GTPase of the outer membrane regulating the anterograde motion of the mitochondria [53, 66]; (4) mitofusin-2 (Mfn2, GTPase of the outer membrane…”
BackgroundPink1 Regulates Tyrosine Hydroxylase Expression and Dopamine Synthesis
Lu, L., Jia, H., Gao, G., Duan, C., Ren, J., Li, Y., & Yang, H. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170832 · Cited by 7
Kim, E.-A. L., Na, J.-M., Kim, J., Choi, S. Y., Ahn, J., & Cho, S. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9733-x · Cited by 7
Neuroinflammation as an Integral Component of Neurodegeneration in Parkinson's Disease
Sayfitdinkhuzhaev, Z. F., Zhukova, N., & Baidanova, A. N. (2024) · Personalized Psychiatry and Neurology · doi:10.52667/2712-9179-2024-4-4-26-33 · Cited by 6
Chowdhury, S. R., Koley, T., Singh, M., Ethayathulla, A. S., & Kaur, P. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188883 · Cited by 6
Masuda, Y. (2011) · Eisei kagaku · doi:10.1248/jhs.57.1 · Cited by 6
Hsp90 as a therapeutic target in endocrinology: current evidence
Ratajczak, T., Ward, B. K., Walsh, J. P., & Cluning, C. (2015) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s68546 · Cited by 8
“…cytoprotective effects may require phosphorylation of TRAP1 by the mitochondrial-localized kinase, PTEN-induced putative kinase (PINK1), 50 in addition to the stabilizing influences of Sorcin, a Ca 2 + -dependent regulator that binds TRAP1 and prevents its proteolytic degradation in…”
Identification of Ser465 as a novel PINK1 autophosphorylation site
Guo, J., Yao, L., Sun, Q., Cui, Y., Yang, Y., Xu, Q., Yan, X., & Tang, B. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0103-7 · Cited by 6
“TRAP1 protein is found to be the substrate of PINK1 [14], through which, PINK1 can reduce the release of mitochondrial cytochrome c and fill the gap caused by cell damage and even cell death under stress.”
Wang, X., Yuan, L., Yan, L., Ye, Y.-B., Lü, B., & Xu, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.920999 · Cited by 6
“PINK1 promotes tumor survival, protects cancer cells from different cytotoxic agents (28), and exerts its biological function through oxidative stress (29).”
BackgroundFGD5-AS1/miR-5590-3p/PINK1 induces Lenvatinib resistance in hepatocellular carcinoma
Song, M., Ma, L., Shen, C., Liu, W., Zhang, P., Bi, R., & Zhao, C. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110828 · Cited by 8
Pathogenesis of Parkinson's Disease
Gupta, A., & Dawson, T. M. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00010-6 · Cited by 7
Hu, J., Tan, E. Y., Campo, L., Leek, R., Seman, Z., Turley, H., Delia, D., Cesario, A., Gatter, K., & Pezzella, F. (2013) · Journal of cancer research updates · doi:10.6000/1929-2279.2013.02.03.5 · Cited by 6
“† Current address: Department of General Surgery, Tan Tock Seng Hospital, Annex Block,11 Jalan Tan Tock Seng, Singapore 308433 ‡ visiting fellow from Department of Pathology, Faculty of Medicine& Science Health, UPM, 431001 Serdarg, Malaysia Established TRAP1 functions also include binding to type 1 TNF receptor, inte…”
BackgroundLohmann, K., & Klein, C. (2008) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000275627.47561.c3 · Cited by 6
“PINK1 presumably exerts its neuroprotective effect by phosphorylating specific mitochondrial proteins, such as the recently identified substrate TRAP1 (Pridgeon et al, 2007).”
BackgroundEditorial: apoptosis in the aging brain
Ziv, I., & Melamed, E. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0536-2 · Cited by 6
Dharaskar, S. P., Paithankar, K., & Subbarao, S. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-34728-1 · Cited by 7
Loughery, J. R., Crowley, E., Kidd, K. A., & Martyniuk, C. J. (2021) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2021.100905 · Cited by 5
Zhu, D., Han, F., Sun, L., Agnihotri, S. K., Hu, Y., & Büeler, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.893396 · Cited by 6
Nand, S., Singh, S. S., Birla, H., Zahra, W., Rathore, A. S., Singh, P., & Singh, S. P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00221 · Cited by 5
“1Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India, 2Department of Biochemistry, Institute of Medical Science, Banaras Hindu University, Varanasi, India Keywords: Parkinson disease, mitochondria, metformin, TRAP1, HtrA2, PINK1”
InfluentialPINK1: One Protein, Multiple Neuroprotective Functions
Valente, E. M., Michiorri, S., Arena, G., & Gelmetti, V. (2009) · Future Neurology · doi:10.2217/fnl.09.39 · Cited by 4
Hsp90: Is There an Unknown Role in Pain Neurobiology
Dias-Ferreira, J., & Neto, F. L. M. (2019) · Heat shock proteins · doi:10.1007/978-3-030-23158-3_25 · Cited by 5
PINK1 mutations and differential effects on mitochondrial function
Tan, E. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.10.018 · Cited by 5
“Third, PINK1 binds and colocalizes with TRAP1 (TNF receptor-associated protein 1) in the mitochondria and phosphorylates TRAP1 (Pridgeon et al. 2007).”
ER stress protection in cancer cells: the multifaceted role of the heat shock protein TRAP1
Matassa, D. S., Arzeni, D., Landriscina, M., & Esposito, F. (2014) · Endoplasmic Reticulum Stress in Diseases · doi:10.2478/ersc-2014-0003 · Cited by 4
“[58] Pridgeon JW, Olzmann JA, Chin LS, Li L: PINK1 protects against”
BackgroundChapter 12 Using Functional Genomics to Study PINK1 and Metabolic Physiology
Schéele, C., Larsson, O. S., & Timmons, J. A. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)05012-5 · Cited by 3
Metadata
- Authors
- Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L.
- Affiliations
- Emory University (US)
- Corresponding author
- Chin, Lih-Shen
- Li, Lian
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-06-19
- Volume
- 5
- Issue
- 7
- Pages
- e172
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC1892574
- OpenAlex
- W2055538245
- Cited by
- 596
- References
- 44
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 20 · 2021: 29 · 2020: 27 · 2019: 14 · 2018: 25 · 2017: 30 · 2016: 21 · 2015: 36 · 2014: 39 · 2013: 39 · 2012: 45
- FWCI
- 42.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (AG021489, R01AG021489)
- National Institute of Neurological Disorders and Stroke (F31NS054597, NS-047199, R01NS047199, NS050650, R01NS050650)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PINK1, TRAP1, Parkinson's disease, oxidative stress, mitochondrial chaperone, protein phosphorylation, cytochrome c release, apoptosis, PINK1 mutations, neurodegeneration
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Base Sequence, HeLa Cells, Humans, Mitochondria, Phosphorylation, Protein Binding, Protein Kinases, Recombinant Proteins, Substrate Specificity, Transfection, PC12 Cells, Apoptosis, Point Mutation, Oxidative Stress, HSP90 Heat-Shock Proteins, Parkinsonian Disorders, RNA, Small Interfering, Cytochromes c, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.